Like much else in US patent litigation, the cost of IPRs skews the system heavily against the small guy
There have been a few suggestions recently that the cost of re-exam procedures should be lowered so that the use of inter partes reviews (IPR) and covered business method (CBM) reviews, are not only affordable for the richest of players in the US…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.